Antitumor activity and pharmacokinetic properties of ARS-interacting multi-functional protein 1 (AIMP1/p43)
- 1 January 2010
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 287 (2) , 157-164
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Interleukin-12: Biological Properties and Clinical ApplicationClinical Cancer Research, 2007
- Molecular pathways of angiogenesis inhibitionBiochemical and Biophysical Research Communications, 2007
- The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactionsCancer and Metastasis Reviews, 2006
- Hormonal activity of AIMP1/p43 for glucose homeostasisProceedings of the National Academy of Sciences, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- The Novel Cytokine p43 Stimulates Dermal Fibroblast Proliferation and Wound RepairThe American Journal of Pathology, 2005
- Dose-dependent Biphasic Activity of tRNA Synthetase-associating Factor, p43, in AngiogenesisJournal of Biological Chemistry, 2002
- A Cofactor of tRNA Synthetase, p43, Is Secreted to Up-regulate Proinflammatory GenesJournal of Biological Chemistry, 2001
- The p43 Component of the Mammalian Multi-synthetase Complex Is Likely To Be the Precursor of the Endothelial Monocyte-activating Polypeptide II CytokineJournal of Biological Chemistry, 1997
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971